What GIP (Glucose-Dependent Insulinotropic Polypeptide) Does Independently On its own, GIP raises insulin after oral glucose
Neither has been directly compared to the other, and cross-trial comparisons are limited by differences in patient populations, dose escalation, and trial duration
Detailed observations from controlled in vitro experiments highlight leptins role in curbing the expansion of human Treg cells
Work on more advanced boosters and alternatives with a proven benefit
Patients at the 6-month mark overwhelmingly describe the decision to start as one of the best they made for their health
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared DSIP for therapeutic use in humans or animals